Replies to post #43 on KORU Medical Systems Inc (KRMD)

[blue_skies]

@J Good find. My first reaction is that the home infusion device being shown is scary. It looks like a children's water gun pump toy.

What I sense is that you see some potential head winds to KRMD's growth? What I see is possible(?) growing pains that will be worked through as companies, such as Grifols, reconfigure drugs for subq. The growing pains are symptomatic of rapid market expansion.


https://www.pharmaceutical-technology.com/news/fda-approves-grifols-xembify-for-immunodeficiencies/
"Grifols plans to launch Xembify in the US in the second quarter of this year. It is also seeking approvals in Canada and Europe."

[blue_skies]

from the article
stressed that there is only a potential, not an actual, shortage of subcutaneous immune globulin,.

to recommend that, for now, no new patients be started on the self-administered form of the drug.

The blood authority anticipated that SCIg use would grow by 20 per cent per year, but instead it jumped by 50 per cent in the past year

When I reflect on your post I wonder if what is happening in Canada is just the tip of the iceberg? Or if what is happening in Canada is unique to Canada?